cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer-Reference-Cited by-同舟云学术

cRGD-Peptide Modified Covalent Organic Frameworks for Precision Chemotherapy in Triple-Negative Breast Cancer

Published:2024-09-13 Issue: Volume: Page:
ISSN:1944-8244
Container-title:ACS Applied Materials & Interfaces
language:en
Short-container-title:ACS Appl. Mater. Interfaces

Author:

Benyettou Farah¹,Khair Mostafa²,Prakasam Thirumurugan¹^ORCID,Varghese Sabu²,Matouk Zineb³,Alkaabi Maryam¹,Pena-Sánchez Pilar⁴^ORCID,Boitet Maylis²,AbdulHalim Rasha¹,Sharma Sudhir Kumar⁵,Ghemrawi Rose⁶⁷,Thomas Sneha²,Whelan Jamie¹^ORCID,Pasricha Renu²,Jagannathan Ramesh⁵^ORCID,Gándara Felipe⁴^ORCID,Trabolsi Ali¹^ORCID

Affiliation:

1. Chemistry Program, New York University Abu Dhabi (NYUAD), Abu Dhabi 129188, United Arab Emirates

2. Core Technology Platforms, New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates

3. Technology Innovative Institute, P.O. Box 9639, Abu Dhabi 9639, United Arab Emirates

4. Instituto de Ciencia de Materiales de Madrid-CSIC, C. Sor Juana Inés de La Cruz 3, Madrid 28049, Spain

5. Engineering Division, New York University Abu Dhabi, 129188 Abu Dhabi, United Arab Emirates

6. College of Pharmacy, Al Ain University, P.O. Box 112612, Abu Dhabi 112612, United Arab Emirates

7. AAU Health and Biomedical Research Center, Al Ain University, P.O. Box 112612, Abu Dhabi 112612, United Arab Emirates

Funder

ASPIRE

New York University Abu Dhabi

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsami.4c10812

Reference77 articles.

1. Cutting-edge approaches for targeted drug delivery in breast cancer: beyond conventional therapies

2. Recent Advances in Targeted Nanocarriers for the Management of Triple Negative Breast Cancer

3. Nano-drug delivery system: a promising approach against breast cancer

4. Gene expression and amplification in breast carcinoma cells with intrinsic and acquired doxorubicin resistance

5. Doxorubicin-polyglycerol-nanodiamond conjugate is a cytostatic agent that evades chemoresistance and reverses cancer-induced immunosuppression in triple-negative breast cancer